Discovery & Challenge: The State of Prostate Cancer Research A Roundtable Discussion with Leading U.S. Experts

Our own Alvin Chin, Prostate Cancer Survivor & Advocate, Virginia Prostate Coalition, joins oncologists Howard Scher MD, Donald S. Coffey, PhD, Peter S. Nelson, MD and representatives from research and the Pharma industry for a round table discussion April 23. You can make your voice heard by joining the conference by phone and emailing questions [...]

A JOINT STATEMENT FROM AMERICA’S PROSTATE CANCER ORGANIZATIONS

The following statement about the recent controversy regarding PSA testing was issued this morning by the thirteen organizations , including Malecare, listed at the bottom of the statement: A JOINT STATEMENT FROM AMERICA'S PROSTATE CANCER ADVOCACY, EDUCATION, AND SUPPORT ORGANIZATIONS Since 1993, when the PLCO trial was started, we have awaited the results of this [...]

The Role of BRCA1 and BRCA2 Gene Mutations in Advanced Prostate Cancer

Sure, we need more research about prostate cancer, but fortunately we also gain from research into other cancers. The commonly referred to breast cancer genes, BRCA1 and BRCA2 might also increase a man’s risk for developing an aggressive strain of prostate cancer. According to a report in Reuters, men with prostate cancer who also carry [...]

Can the Prostate Cancer Community Finally Come Togrther?

Yesterday afternoon I participated in a conference call, which included representatives from most of the major prostate cancer organizations in the United States. Alvin Chin and John Willey who serve as consumer advocates for the Department of Defense Congressionally Directed Medical Research programs (DOD CDMRP) prompted the call. Alvin and John serve specifically on the [...]

Go to Top